Phibro Animal Health (PAHC) Net Cash Flow (2016 - 2026)
Phibro Animal Health has reported Net Cash Flow over the past 13 years, most recently at -$16.8 million for Q4 2025.
- For Q4 2025, Net Cash Flow fell 188.84% year-over-year to -$16.8 million; the TTM value through Dec 2025 reached -$13.0 million, down 134.38%, while the annual FY2025 figure was -$1.4 million, 104.38% down from the prior year.
- Net Cash Flow for Q4 2025 was -$16.8 million at Phibro Animal Health, down from $4.6 million in the prior quarter.
- Over five years, Net Cash Flow peaked at $23.1 million in Q4 2021 and troughed at -$31.2 million in Q1 2023.
- A 5-year average of $1.3 million and a median of $3.0 million in 2022 define the central range for Net Cash Flow.
- Biggest five-year swings in Net Cash Flow: surged 755.51% in 2022 and later tumbled 1010.17% in 2024.
- Year by year, Net Cash Flow stood at $23.1 million in 2021, then plummeted by 137.13% to -$8.6 million in 2022, then increased by 6.7% to -$8.0 million in 2023, then surged by 336.3% to $18.9 million in 2024, then plummeted by 188.84% to -$16.8 million in 2025.
- Business Quant data shows Net Cash Flow for PAHC at -$16.8 million in Q4 2025, $4.6 million in Q3 2025, and $6.5 million in Q2 2025.